Nagoya, Japan

Kentaro Sahashi

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Aichi Medical University, Knc Laboratories Co., Ltd., National University Corporation Shiga University of Medical Science. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kentaro Sahashi. Retrieved from https://idiyas.com/inventor/kentaro-sahashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.9

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kentaro Sahashi: Innovator in Antisense Oligonucleotide Technology

Introduction

Kentaro Sahashi is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides.

Latest Patents

Sahashi holds a patent titled "Antisense oligonucleotide controlling expression amount of TDP-43 and use thereof." This invention provides a suppression type antisense oligonucleotide targeting TDP-43 mRNA. It contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in any of SEQ ID NOs: 2-4. Additionally, it includes a promotion type antisense oligonucleotide targeting TDP-43 mRNA, which contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in SEQ ID NO: 5.

Career Highlights

Throughout his career, Kentaro Sahashi has worked with prestigious institutions, including Osaka University and Knc Laboratories Co., Ltd. His work has focused on advancing the understanding and application of antisense technology in medical research.

Collaborations

Sahashi has collaborated with notable colleagues such as Yoshitaka Nagai and Kazuhiro Maeta. Their combined expertise has contributed to the success of various research projects.

Conclusion

Kentaro Sahashi's innovative work in antisense oligonucleotide technology highlights his role as a key figure in molecular biology. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…